Confirmatory efficacy and safety evaluation of MB-105, a CD5.CAR T therapy: Multicenter phase 2 study in patients with relapsed/refractory T cell lymphoma (R/R TCL) Meeting Abstract
| Authors: | Iyer, S. P.; Hill, L.; Horwitz, S.; Jain, S.; Poh, C.; Vose, J. M.; Brenner, M. K.; Mamonkin, M.; Hein, S.; Giordano, F.; Bexon, A. |
| Abstract Title: | Confirmatory efficacy and safety evaluation of MB-105, a CD5.CAR T therapy: Multicenter phase 2 study in patients with relapsed/refractory T cell lymphoma (R/R TCL) |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 7223 |
| Language: | English |
| ACCESSION: | WOS:001412805000045 |
| DOI: | 10.1182/blood-2024-201523 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
